Investment Co PJSC Mubadala

CIK 1704268 · last filed 2025-09-11

Investment Co PJSC Mubadala is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for GFS, was dated May 26, 2026. Across all open-market trades the lifetime net is −$21024.00T, making them a net seller over the disclosed history. Current disclosed insider exposure totals $35.98B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$35.98B

Companies

3

Total Filings

14

Lifetime Open-Market Net

-$21024001.24B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RXRX 10%+ Owner 12,985,927 $3.56 $46.23M $2.28M 7 2023-03-03
GAIA 0 $1.54 $0 $388.6K 1 2019-05-14
AMD Director 75,000,000 $479.18 $35.94B -$21024001.24B 3 2019-02-07

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-26 GFS Notice (144) −22,000,000 -$1.98B EDGAR
2025-09-11 Buy (P) +5,001,324 $129.78M
2025-03-27 Other (J) −4,465,494 -$122.80M
2023-03-03 RXRX Buy (P) +133,644 $1.04M EDGAR
2023-03-01 RXRX Buy (P) +1,630 $13.0K EDGAR
2023-02-24 RXRX Buy (P) +103,728 $807.6K EDGAR
2023-02-15 RXRX Buy (P) +12,600 $100.1K EDGAR
2023-02-13 RXRX Buy (P) +22,000 $175.6K EDGAR
2023-02-02 RXRX Buy (P) +1,200 $9.6K EDGAR
2023-01-27 RXRX Buy (P) +15,772 $126.0K EDGAR
Showing 110 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.